التفاصيل البيبلوغرافية
| العنوان: |
IMPORT-201 (IMP-MEL): A phase 1 first-in-human dose finding/randomized phase 2 study of a novel iNKT agonist IMM60 and pembrolizumab for advanced melanoma and metastatic non-small cell lung cancer (NSCLC). |
| المؤلفون: |
Coupe, Nicholas, Pinato, David J. James, Fairchild, Justin P., Pastore, Desa Rae Electa, Innaimo, Steven, Thompson, David, Gileadi, Uzi, Kramer, Robert A., Walters, Ian B., Middleton, Mark R. |
| المصدر: |
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p2575-2575, 1p |
| قاعدة البيانات: |
Supplemental Index |
